 4 WEEK 2 WAY CROSSOVER DOUBLE BLIND TREATMENT PHASE WITH COMBIVENT CFC VERSUS ALBUTEROL FOLLOWED BY A 4 WEEK OPEN LABEL COMBIVENT RESPIMAT WHEN ALL DRUGS ARE USED FOR SYMPTOM RELIEF AS NEEDED IN PTS WITH MODERATE TO SEVERE ASTHMA: 